IL4 and Granuloma: Our results showed that the lungs from CFA-inoculated mice treated with anti-IL-4 mAb showed smaller granulomas, milder disruption of the pulmonary parenchyma and reduced infiltration of inflammatory cells in comparison with CFA- IgG-treated control mice (Figure 6, A and B).